Course Description
Starts 5/31/2024 | Expires 5/31/2025
This initiative is designed to help primary care clinicians establish practice-level strategies for enhancing patient-centered care of diabetes with diabetes technology. The educational strategies learned through this program will address the opportunities for implementation in practices of various sizes and resources.
Accreditation and Designation Statements
Physicians and Physician Assistants
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 1.25 contact hour.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
-
Examine various approaches to implementing diabetes technologies such as continuous glucose monitors (CGMs) into practice workflows and systems such as team roles, documentation, data interpretation, communication, billing, and coding — even with limited resources.
-
Address tactics to overcome and provide alternative options to patient resistance to technology, lack of finances, and tackling multiple comorbidities.
-
Identify resources to help patients use their diabetes technology devices allowing them to become more successful at achieving their prescribed metabolic targets.
Target Audience
Primary care physicians, nurse practitioners (NPs), nurses, physician associates (PAs), diabetes care professionals, and other HCPs treating patients with diabetes in their practice.
Disclosures and Conflicts of Interest
The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Amy Ogunsunlade - No relationships to disclose
Diane Alberson, MEd, CAE - No relationships to disclose
Dan O’Sullivan – No relationships to disclose
Alice Kelly - No relationships to disclose
Maria A Mogollon APRN, FNP-BC - No relationships to disclose
Armand Krikorian, MD, MBA - Doximity Inc: Stock ownership
Jeffrey Unger, MD, FAAFP, FACE, DACT - Abbott Diabetes: Consultant, Speakers bureau; Dexcom: Consultant; Novo Nordisk: Stock ownership, Speakers bureau
Armand Krikorian, MD, MBA discloses the following:
Jeffrey Unger, MD, FAAFP, FACE, DACT discloses the following:
-
Abbott Diabetes: consultant, speakers bureau
-
Dexcom: consultant
-
Novo Nordisk: stock ownership, speakers bureau
Maria A. Mogollon, APRN, FNP-BC has no relevant financial information to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
Commercial Support
This activity is supported by educational grants from Novo Nordisk, Medtronic Inc., and Abbott Diabetes Care.
Faculty
Armand Krikorian, MD, MBA
Chief Medical Officer
UChicago Medicine
AdventHealth
Bolingbrook, IL
Jeffrey Unger, MD, FAAFP, FACE, DACD
Director
Unger Primary Care Concierge Medical Group
Rancho Cucamonga, CA
Maria A. Mogollon, APRN, FNP-BC
Obesity/Diabetes/Metabolism APRN-IMG
Miami, FL
Price
Free
Purchase URL
https://my.aace.com/NC__Product?id=a1BPo000002LAXuMAO